Inside Rx: Discounts Available for Insulin and Other
The discounts seem to be greater for insulin products (mostly in the 40%-50% range) than for diabetes pills (around 20%-30% off). See below for a full list of diabetes medications currently available for discounted purchase with an Inside Rx …
Actived: 9 days ago
Getting Insulin During COVID-19 diaTribe
However, your immune system (which runs your body’s ability to fight off viruses like COVID-19) is weakened when your blood sugars run too high for long periods of time. That’s why it is especially important to carefully manage your blood glucose levels during this pandemic. To do so, make sure that you have and are able to access as much
How Can I Pay for Diabetes Medications and Care
The trade-off is that there will likely be higher out-of-pocket costs for out-of-network services. An EPO (Exclusive Provider Organization) offers lower premiums (monthly fees) and out-of-pocket costs, as well as direct access to specialists without a referral.
FDA Approves Novo Nordisk’s Saxenda as a Treatment for
Twitter summary: FDA approves Novo Nordisk’s chronic weight management drug Saxenda, another option to help treat #obesity On December 23, the FDA approved Novo Nordisk’s Saxenda (liraglutide injection) as a treatment option for weight management, to be taken in addition to a reduced-calorie diet and physical activity. The drug is approved for use in people with a body mass
FreeStyle Libre Now Available in Major US Pharmacies
By Amelia Dmowska and Adam Brown. Abbott’s no-calibration CGM available at pharmacies like CVS and Walgreens for a cash price ranging from about $36-$53/ 10-day sensor; g et cost and prescription details here. Want more news just like this? Sign Up Now! Two months after approval by the Food and Drug Administration (FDA), Abbott’s FreeStyle Libre (real time) continuous glucose monitor (CGM
Ultra Rapid-Acting Inhaled Insulin Afrezza Now Available
Twitter Summary: Sanofi + MannKind Afrezza now available in some US pharmacies; prices comparable to Novolog/Humalog, @afrezzauser gives patient perspective! Update (2/3/15): Today, Sanofi and MannKind announced the official launch of the ultra rapid-acting inhaled-insulin Afrezza. The insulin is now available at pharmacies nationwide.
Medicare Now Covers Abbott’s FreeStyle Libre CGM diaTribe
Dexcom has had to turn off this function in its G5 Medicare system, a tremendous frustration for users due to the current Medicare reimbursement codes. We know that Dexcom is working to fix this, along with a number of patient and organizational advocates. Unfortunately, there is no timing to report, but we hope to see this policy overturned as
Abbott’s FreeStyle Libre – Transforming Glucose Monitoring
Adam experienced nine blood glucose readings <80 mg/dl over the two-week period, and on average, FreeStyle Libre was about 11% off vs. 8% for the Dexcom G4 Platinum. Lag time between the meter value and the sensor value was similar with FreeStyle Libre and the Dexcom G4 Platinum – about five to ten minutes at most.
In a Race for a New and Cheaper Insulin Glargine, Legal
Do you ever wonder why there aren’t cheaper “generic” insulin products available? This may soon change as the patents for branded insulin begin to expire. In fact, the patents for Sanofi’s top-selling Lantus (basal insulin glargine) are set to expire in the US in 2015, and other companies are racing to produce new “generic” insulins that could provide more choices for patients
Abbott’s FreeStyle Libre Approved in US to Replace Routine
For those under 18 years, this means a healthcare provider will need to prescribe FreeStyle Libre “off-label.” This is doable but depends on the provider. Outside the US, FreeStyle Libre is approved down to age four. We hope to see Abbott and FDA work to update the US label and add pediatrics, now that it is approved in adults.